(IVE) SP500 Value - Overview
Etf: Large-Cap, Value, Equities, Sectors
Dividends
| Dividend Yield | 1.71% |
| Yield on Cost 5y | 2.82% |
| Yield CAGR 5y | 4.79% |
| Payout Consistency | 96.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.2% |
| Relative Tail Risk | 2.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.71 |
| Alpha | 2.16 |
| Character TTM | |
|---|---|
| Beta | 0.755 |
| Beta Downside | 0.824 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.58% |
| CAGR/Max DD | 0.86 |
Description: IVE SP500 Value January 29, 2026
The iShares S&P 500 Value ETF (IVE) tracks an index that reflects the performance of large-cap U.S. stocks classified as “value” based on low price-to-book and price-to-earnings ratios. The fund is required to hold at least 80 % of its net assets in the index’s constituent equities, while the remaining 20 % may be allocated to cash, futures, options, or swap contracts for liquidity or tactical positioning.
As of 29 January 2026, IVE carries an expense ratio of 0.15 % and manages roughly $23 billion in assets (Morningstar). Its three largest holdings are Berkshire Hathaway Class B (≈ 5 % of assets), JPMorgan Chase & Co. (≈ 4 %), and Johnson & Johnson (≈ 3 %). Sector exposure is dominated by Financials (≈ 30 % of assets) and Health Care (≈ 20 %), both of which have shown relative resilience in a rising-rate environment.
Key macro drivers for large-cap value stocks include the Federal Reserve’s policy stance and corporate earnings trends. The current Fed funds rate of 5.25 %–5.50 % compresses earnings multiples, which historically benefits value-oriented firms with stable cash flows. Additionally, the U.S. corporate earnings growth rate of 3.8 % YoY (Q4 2025) is above the S&P 500 average, supporting the sector’s outperformance potential.
For a deeper, data-rich comparison of IVE against other value-focused ETFs, you might explore ValueRay’s analytics platform.
What is the price of IVE shares?
Over the past week, the price has changed by +2.22%, over one month by +2.67%, over three months by +7.79% and over the past year by +15.11%.
Is IVE a buy, sell or hold?
What are the forecasts/targets for the IVE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 256.6 | 15.5% |
IVE Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 48.95b USD (48.95b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 48.95b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 48.95b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.70% (E(48.95b)/V(48.95b) * Re(8.70%) + (debt-free company))
Discount Rate = 8.70% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)